Dr. David J Frank MD

Due to the fact that symptoms and progression rates of MS vary among patients with the disease, previous implications have been made to suggest that MS may involve a combination of two or more different diseases.New findingsMost recently, a study used computational simulations to assess whether it...

In 2017, the United States Food and Drug Administration (USFDA) approved the drug – Ocrevus (ocrelizumab) – as a treatment for both relapsing and progressive forms of multiple sclerosis. ...

Research shows that patients newly diagnosed with Alzheimer's disease who recently began using antidepressents are at a higher risk for head injuries and traumatic brain injuries. Heidi Taipale and colleagues from the University of Eastern Finland wrote that for older people who use...

Few disease are more difficult to treat than those related to the brain and nerves. Since it is the body’s control center, having diseases caused by malfunctions in the brain can have multiple effects on the body. Not only are doctors trying to cure or control the root cause, relief for multiple...

Muscular dystrophy is a neuromuscular disease that takes on multiple forms. It is caused by a genetic mutation, which makes cells unable to produce the proteins necessary for muscular growth. In muscular dystrophy, the tissues eventually break down and cause progressive muscular weakness.This...

Pristiq and Effexor are medications that have similar compositions and are produced by the same manufacturing company. Pristiq (desvenlafaxine) is an antidepressant, which has been recently approved by the FDA. The composition of Pristiq is similar to Wyeth’s existing antidepressant. The patent...